Literature DB >> 2415665

bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia.

C R Bartram.   

Abstract

Southern blot analysis detected a bcr gene rearrangement within leukemic cells of a Philadelphia chromosome-negative chronic myelocytic leukemia (CML) patient that led to transcription of a novel 7.3 kb bcr RNA species. Participation of the c-abl oncogene in this genomic recombination could be ruled out by in situ hybridization studies and Northern blot analysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415665      PMCID: PMC2187996          DOI: 10.1084/jem.162.6.2175

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

2.  Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation?

Authors:  A Hagemeijer; C R Bartram; E M Smit; A J van Agthoven; D Bootsma
Journal:  Cancer Genet Cytogenet       Date:  1984-09

3.  Chromosomes and cancer: new nomenclature and future directions.

Authors:  J J Yunis
Journal:  Hum Pathol       Date:  1981-06       Impact factor: 3.466

4.  Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia.

Authors:  C R Bartram; A de Klein; A Hagemeijer; T van Agthoven; A Geurts van Kessel; D Bootsma; G Grosveld; M A Ferguson-Smith; T Davies; M Stone
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

5.  Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment.

Authors:  W C Pugh; M Pearson; J W Vardiman; J D Rowley
Journal:  Br J Haematol       Date:  1985-07       Impact factor: 6.998

6.  An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.

Authors:  R P Gale; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  DNA content and DNA-based centromeric index of the 24 human chromosomes.

Authors:  M L Mendelsohn; B H Mayall; E Bogart; D H Moore; B H Perry
Journal:  Science       Date:  1973-03-16       Impact factor: 47.728

8.  Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.

Authors:  J B Konopka; S M Watanabe; J W Singer; S J Collins; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.

Authors:  A de Klein; A G van Kessel; G Grosveld; C R Bartram; A Hagemeijer; D Bootsma; N K Spurr; N Heisterkamp; J Groffen; J R Stephenson
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  6 in total

Review 1.  Molecular analysis of Philadelphia chromosome positive leukaemias.

Authors:  B D Young
Journal:  Br J Cancer Suppl       Date:  1988-12

Review 2.  Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia.

Authors:  J L Huret
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

3.  Organ Specific Tumor Markers: What's New?

Authors:  Kannan Vaidyanathan; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2011-11-08

4.  Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.

Authors:  C R Bartram; J W Janssen; R Becher; A de Klein; G Grosveld
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

5.  Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?

Authors:  Gustavo S Fernandes; Daniel F Marques; Daniel M Girardi; Maria Ignez F Braghiroli; Renata A Coudry; Sibele I Meireles; Artur Katz; Paulo M Hoff
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

6.  Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.

Authors:  Andreas Hochhaus; Franҫois-Xavier Mahon; Philipp le Coutre; Ljubomir Petrov; Jeroen J W M Janssen; Nicholas C P Cross; Delphine Rea; Fausto Castagnetti; Andrzej Hellmann; Gianantonio Rosti; Norbert Gattermann; Maria Liz Paciello Coronel; Maria Asuncion Echeveste Gutierrez; Valentin Garcia-Gutierrez; Beatrice Vincenzi; Luca Dezzani; Francis J Giles
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-21       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.